1
Disclosures
Feb 5, 2026 — Feb 5, 2026
Date Range
PRIME
Market Segment
Pharmaceutical
Sector

Disclosures

DateTypeHeadlinePDF
Feb 5 Earnings SANTEN PHARMACEUTICAL CO.,LTD. Reports Q3 FY2026 Earnings Presentation: Revenue of 211 billion PDF

Disclosure Types

Earnings: 1